Navigation Links
Boffins Identify Gene That can Protect Humans from Nephronopthisis

Researchers from the European Molecular Biology Laboratory (EMBL) and the University of Michigan have identified a gene that can protect humans from nephronopthisis (NPHP), a serious kidney disease .

NPHP is a disease that causes kidney degeneration during childhood and kidney failure requiring organ transplantation. The insights might help design effectual and non-invasive therapies.

The team has discovered that mutations in the gene GLIS2 can lead to nephronopthisis (NPHP) in both humans and mice.

Mathias Treier and his group at EMBL have paved way to develop innovative treatment for the disease by working on a mouse model.

"Our mice show striking similarities with NPHP patients. Very early on in their lives their kidney cells start to die and the mice develop all the characteristic disease symptoms. It is the first time that a mouse model reveals increased cell death as the mechanism underpinning kidney degeneration in NPHP. The genetic cause is a mutation in a gene called GLIS2," Nature Genetics quoted Mathias Treier, group leader at EMBL, as saying.

GLIS2 protects adult kidney against cell death by turning off genes that trigger cell death, and that are necessary for the organ development.

A change in the GLIS2 function sets off harmful genes leading to large numbers of kidney cells' death..

To see if GLIS2 has the same result on human, Friedhelm Hildebrandt and his team at the University of Michigan carried out a genetic screening of those having NPHP. They found that some patients carried mutations in the same GLIS2 gene as in the mouse model confirming that GLIS2 is a crucial player in NPHP also in humans.

"This is an excellent example of how combining basic research with clinical studies can help uncovering mechanisms of human disease," said Henriette Uhlenhaut who carried out the research in Treier's lab.

"The next step will be
'"/>




Page: 1 2

Related medicine news :

1. Fizzy Logic For A Perfect Drink: Courtesy Boffins
2. Boffins Identify Fifth Gene Behind Joubert Syndrome
3. Boffins Find Link Between Common Sleep Disorder and Hypertension
4. Boffins Identify Molecule That Might Treat Food Allergy
5. Boffins a Step Closer to Solving Puzzle of Lou Gehrigs Disease
6. Boffins Identify Gene That Helps Regulates Body Weight
7. Boffins Link Atkins Diet With Bowel Cancer
8. Boffins Develop New Technique to Hunt Illness-causing Mutants in Non-gene DNA
9. Boffins Find Evidence for Novel Brain Cell Communication
10. Indian Boffins to Fight Wrinkles With Camels Milk
11. Laboratory Testing Can Identify Risk of Pre-Term Labor and Delivery
Post Your Comments:
(Date:10/7/2008)... WASHINGTON, Oct. 7 /PRNewswire-USNewswire/ -...ight for the second presidential debate, Jean,Berg...e Florida, will be in,the audience, waiting to ask...ts and make it harder for families to afford cover...y 28 years and has never had,healthcare., "It,s t...
(Date:10/7/2008)... Compression ultrasound similar to more expensive... , TUESDAY, Oct. 7 (HealthDay News) -- An o...leg -- called deep vein thrombosis, or DVT -- is a...esearch says. , European researchers found that...alled compression or duplex ultrasound -- was as g...
(Date:10/7/2008)... SEDONA, Ariz., Oct. 7 /PRNewswire/ -- Join M...or a four-day celebration in Sedona,s red rock,cou...Activities include a,series of traditional Native ... Program Director R.J. Joseph and special guest, E...espected Blackfoot Elder from the Blood Reserve,in...
(Date:10/7/2008)... MORE THAN 100,000 PEOPLE ACROSS THE NATION H... CURE(R), DALLAS, Oct. 7 /PRNewswire/ -- To...d all voters about the positions of presidential c... key health care and cancer issues,the Susan G. K...led a,series of resources available on its web sit...
Breaking Medicine News(10 mins):Health News:SEIU Member Will Be in Town Hall Audience, Ready to Ask John McCain Why He Won't Provide Affordable Healthcare for All 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3Health News:Mii amo Honors Winter Solstice With Traditional Native American Celebration December 18-21 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 3
...certain chemicals has been known to be associated ...etc. from time immemorial. But it is known not unt...eased // following occupational exposure to minera...matiod factor remains unestablished. However, a nu...
...w kind of rat that will help them to study the eff... women that can lead to hypertension and heart fai... of Medicine // have created a better research rat...olved in hypertension. These rats will allow them ...
...iversity in New York are under investigation for a...esearch studies and filing false information on pr...th (NIH) to maintain government funding for a univ...cher at the pediatric center accused the center’s ...
...logical levels free radicals and antioxidants in d...ell established following our improved understandi...ential scope because of the fact that confirmation...that treatment for such disorders can be made very...
Other Medicine News:Health News:Protection against Alzheimer’s could be as simple as drinking green te 2
(Date:10/7/2008)...ss., Oct. 7 /- Taligen Therapeutics I...f the Company,s pipeline,candidates were presented...Basel, Switzerland. The data highlighted the candi...ment-mediated diseases., "These highlighted prese...ented at the conference, reveal the deep expertise...
(Date:10/7/2008)...pective Randomized Placebo-Controlled Phase II Stu...ed Overall Survival., MOUNTAIN VIEW, California, ...s now evaluated the mature Phase II data from the,...TVAC(TM) that had been,obtained as part of the rec... Institute (NCI) in the US., The results from the...
(Date:10/7/2008)...nded to Eight On-Demand Tests for Use on the GeneX...UNNYVALE, Calif., Oct. 7 /-...e of Xpert(TM) vanA/vanB as a European CE,IVD Mark...Diagnostic,Medical Devices. The test delivers rapi...ost commonly associated with vancomycin-resistant,...
(Date:10/6/2008)...J., Oct. 6 /- Pharmasset, I...mith, Ph.D., is joining the,Company as Vice Presid...ions. Dr. Smith will be responsible for all invest... Chief Financial Officer Kurt,Leutzinger., Most r... Biotechnology,Analyst at JPMorgan Securities, and...
Breaking Medicine Technology:In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 2Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 3Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 4Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 2Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 3ImaRx Schedules Release of First Quarter 2008 Financial Results 5198 1Researchers find gene location that gives rise to neuroblastoma an aggressive childhood cancer 18719 1Researchers find gene location that gives rise to neuroblastoma an aggressive childhood cancer 18719 2Researchers find gene location that gives rise to neuroblastoma an aggressive childhood cancer 18719 3MIT study suggests caution on new anti obesity drug in kids 18717 1MIT study suggests caution on new anti obesity drug in kids 18717 2Patients with chronic illness benefit from telehealth intervention 18715 1Patients with chronic illness benefit from telehealth intervention 18715 2
...ESS WIRE)--Jun 19, 2007 - Geron,Corporation (Nasda...the scalable production, survival following engraf...nfarcted rats was presented,today for GRNCM1, the ...herapeutic for heart failure, at the International...ting in Cairns,Australia., The presentation was o...
...ne 19, 2007 /PRNewswire-FirstCall/ --,Genaera Corp...ter,on trodusquemine (MSI-1436), its novel anti-ob...iation (ADA) 67th Scientific,Sessions, June 22 to ..., "Trodusquemine is a Multiple,Pathway Inhibitor t...sity, and Improves Plasma Insulin and Leptin Level...
Other Medicine Technology:Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 2Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 3Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 4Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 5Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 6Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 2Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 3Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 4
The DLP Elongated One-Piece Arterial Cannulae features a longer body for easier access during conventional and minimally invasive procedures
The Select Series® Arterial Cannulae utilize a state-of-the-art dip-molding technology. This process allows molding of a one-piece, wire-wound cannula that is flexible and kink-resistant.
Intermittent catheter
Intermittent catheter
Medicine Products: